Metabolic Pathways and Immune Interactions in Renal Cell Carcinoma
Renal cell carcinoma is increasingly recognized as a metabolic disease driven by genetic alterations that regulate cellular energetics, and recent advances in targeting these pathways are highlighted, alongside emerging metabolic biomarkers and imaging modalities.